PNUR 1104 Lecture 1 Overview_sound-1

Embed Size (px)

Citation preview

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    1/76

    PNUR 1104Pharmacology for HealthProfessionals

    Overview of Pharmacology

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    2/76

    Overview of Pharmacology

    PNUR 1104 Online

    Pharmacology for Health

    Professionals

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    3/76

    Objectives

    Define selected key pharmacologicalterms

    Identify common sources of drugs

    Discuss how drugs are classified

    Differentiate between chemical,generic, and trade names of drugs

    Identify sources of drug information

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    4/76

    Objectives

    Summarize the standards and lawswhich govern drug use.

    Discuss the categories of controlledsubstances.

    Discuss the role of the Food and DrugAdministration.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    5/76

    Definition of Terms

    Pharmacology

    Drug

    Drug therapy

    Medication

    Local effects

    Systemic effects

    Prototype

    Drug classification

    Therapeuticclassification

    Pharmacologic orchemicalclassification

    Chemical name

    Generic name

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    6/76

    Definition of Terms

    Trade or brand name

    Bioequivalent

    Prescription drugs Non-prescription or over-the-counter

    (OTC) drugs

    Controlled substances

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    7/76

    Sources of Drugs

    Historically derived from plants

    Synthetic drugs manufactured in labs

    Semisynthetic drugs are naturallyoccurring substances that have beenchemically altered.

    Biotechnology ( recombinantdeoxyribonucleic acid technology)

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    8/76

    Drug Classification

    Similar drugs are grouped togetherfor purpose of study & for ease ofprescribing.

    Drugs are classified according to theireffects on particular body systems,their therapeutic uses & their

    chemical characteristics.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    9/76

    Drug Classification

    Pharmacologic classification

    Therapeutic classification

    Chemical classification Other classifications: Body system,

    General use, Family, Primary action,and indication.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    10/76

    Drug Classification

    Example: Morphine is a CNS

    depressant, narcotic analgesic &opiate as well as the prototype ofnarcotic analgesics.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    11/76

    Uses of Drugs

    Therapeutic uses

    Palliative uses

    Prophylactic uses Diagnostic uses

    Replacement uses

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    12/76

    Drug Nomenclature

    Chemical name

    Generic or nonproprietary name

    Trade (Brand) or proprietary name

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    13/76

    Sources of Drug Information

    Pharmacologytextbooks

    Drug reference

    books: Physiciansdesk reference(PDR), Nursingdrug reference

    books

    Journal articles &newsletters

    Internet sites

    Poison ControlCenters

    Clinicians andPharmacists

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    14/76

    Laws and Standards

    State laws regulate some aspects ofdrug use, sale and distribution, butfederal laws regulate most majoraspects. Food and Drug Administration (FDA)

    Public Health Service

    Federal Trade Commission

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    15/76

    Laws and Standards

    Pure Food & DrugAct of 1906

    Sherley

    Amendment of1912

    Harrison NarcoticAct of 1914

    Food, Drug &Cosmetic Act of1938

    Amendment of1945

    Durham-HumphreyAmendment of

    1952

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    16/76

    Laws and Standards

    Kefauver-HarrisAmendment of1962

    ComprehensiveDrug AbusePrevention &Control Act of1970 (ControlledSubstance Act)

    Drug RegulationReform Act of1978

    Orphan Drug Actof 1983

    FDA ModernizationAct of 1997

    Drug Price &Patent TermRestoration

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    17/76

    Categories of ControlledSubstances

    Schedule I: not approved for medical use,have high abuse potential

    Schedule II: used medically & have high

    abuse potential Schedule III: less potential for abuse

    Schedule IV: some potential for abuse

    Schedule V: contain moderate amounts ofcontrolled substances

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    18/76

    FDA Pregnancy Categories

    Category A: Remote risk of fetalharm

    Category B: Slightly More risk than A

    Category C: Greater risk than B

    Category D: Proven risk of fetal

    harm Category X: Proven risk of fetal

    harm

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    19/76

    Drug Approval Process

    FDA is responsible for approving allnew drugs and certain other aspectsof drug use - reviews all researchstudies related to drugs. Does not dotesting itself.

    Newly developed drugs have to be

    extensively tested.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    20/76

    Testing Process

    Begins with animal studies -reviewed by the FDA for approval togo to next step.

    Next is clinical trials in humans:

    Phase I, Phase II, Phase III, Phase IV(FDA evaluates data)

    Double-blind, placebo controlled,crossover studies, control studies andsubject matching

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    21/76

    Cellular physiology

    Because all body functions, diseaseprocesses, and most drug interactionstake place at the cellular level, wemust understand cellular physiology.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    22/76

    Cellular physiology

    Each body cell has the capacity tofunction and respond to injury.

    Although cells differ in various tissuesaccording to location & function, theyhave common characteristics: Exchange materials with their environment

    Communicate with each other

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    23/76

    Characteristics of InflammatoryResponse

    The characteristics of theinflammatory response can be localor systemic reactions. Thesereactions may vary according to thecause and/or extent of the injury.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    24/76

    Characteristics of InflammatoryResponse

    LOCAL REACTION:

    Erythema or redness

    Heat

    Edema or swelling

    Pain

    Purulent discharge

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    25/76

    Characteristics of InflammatoryResponse

    SYSTEMIC REACTION:

    Leukocytosis ( increased WBCs)

    Increased erythrocyte sedimentation rate(ESR)

    Fever

    Headache

    Loss of appetite Lethargy

    Weakness

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    26/76

    Questions?

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    27/76

    Basic Concepts andProcesses

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    28/76

    Objectives

    Identify factors that decreaseabsorption of an oral drug.

    Identify mechanisms of drugmovement in the body.

    Discuss absorption, distribution,metabolism, and excretion of drugs in

    the body.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    29/76

    Objectives

    Discuss the main elements of thereceptor theory of drug action.

    Discuss variables that effect drugactions in the body.

    Identify adverse effects of drugs onthe body.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    30/76

    Definition of Terms

    Pharmacotherapeutics

    Pharmacokinetics

    Passive diffusion

    Facilitated diffusion

    Active transport

    Absorption

    Distribution

    Metabolism

    Excretion

    Serum half-life

    Pharmacodynamics

    Dose

    Dosage

    Toxic dose

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    31/76

    Definition of Terms

    Lethal dose

    Route ofadministration

    Drug-dietinteraction

    drug-druginteraction

    Additive effects

    Synergism

    Interference

    Displacement

    Agonist

    Antagonist

    Pharmacogenetics

    Pharmaco-anthropology

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    32/76

    Definition of Terms

    Adverse effects orside effects

    Therapeutic effects

    Toxic effects

    Hepatotoxicity

    Nephrotoxicity

    Ototoxicity

    Hypersensitivity orallergic reaction

    Drug fever

    Idiosyncrasy

    Anaphylactic

    reaction Drug dependence

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    33/76

    Definition of Terms

    Carcinogenicity

    Teratogenicity

    Tolerance

    Cross tolerance

    Metabolite

    Drug action

    Onset of action

    Peak of action

    Duration of action

    Therapeutic blood

    level

    Peak blood level

    Toxic blood level

    Indication(s) Contraindications

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    34/76

    Definition of Terms

    Precautions

    Incompatibility

    Loading dose

    Maintenance dose

    Cumulative effects

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    35/76

    Mechanisms of Drug Movement

    To act on body cells, drugs given forsystemic effects must reach adequateconcentrations in blood & other tissue fluids

    surrounding the cells. Thus, they mustenter the body & be circulated in thebloodstream. After they act on cells, theymust be eliminated from the body, as are

    other chemical bodies.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    36/76

    Mechanisms of Drug Movement

    Passive diffusion: higher to lower

    Facilitated diffusion: drug moleculescombine with a carrier substance

    Active transport: lower to higher

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    37/76

    Mechanisms of Drug Movement

    Drug movement & therefore drugaction are affected by a drugs abilityto cross cell membranes. Cell

    membranes are complex structurescomposed of lipid & protein:

    Lipid soluble drugs

    Water soluble drugs

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    38/76

    Pharmacokinetics

    Absorption:

    Dosage form

    Route of

    administration GI function

    Increased gastricemptying

    Food in thestomach

    SQ or IM injections

    IV therapy

    Skin absorption

    Mucous membrane

    Lungs

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    39/76

    Pharmacokinetics

    Distribution: involves thetransport of drug molecules withinthe body. Carried to sites of action, metabolism &

    excretion Depends largely on adequacy of circulation

    Protein binding

    Only free or unbound portion of drug acts onbody cells

    Drug distribution in CNS is unique

    Drug distribution during pregnancy &lactation is unique

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    40/76

    Pharmacokinetics

    Metabolism: method by which drugsare inactivated or biotransformed bythe body. Changed into one or more inactive metabolites

    & excreted

    Kidney can only excrete water solublesubstances

    Most drugs are metabolized by enzymes in theliver

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    41/76

    Pharmacokinetics

    Metabolism:

    Enzyme induction

    Enzyme inhibition

    Rate of metabolism

    Oral drugs absorbed in the GI tract thatare extensively metabolized in the liver

    reduce systemic circulation

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    42/76

    Pharmacokinetics

    Excretion: refers to elimination of adrug from the body.

    Requires adequate functioning of the

    circulatory system & organs of excretion

    Most drugs are excreted by the kidneys Bile

    Feces

    Lungs

    Skin

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    43/76

    Pharmacokinetics

    Serum half-life: also called elimination half-time, isthe time required for the serum concentration of adrug to decrease by 50%.

    Determined primarily by drugs rates ofmetabolism & excretion

    Short half life require more frequentadministration

    4-5 half lives are required to achieve steady-state concentrations

    Eliminated gradually over several half-lives

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    44/76

    Pharmacodynamics

    Receptor theory of drug action

    Specific receptors: enzymes, proteins,nucleic acids

    Changes in cellular metabolism

    Changes permeability of cell membrane

    Modifies physiologic process of cell

    Receptors vary in type, location &number

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    45/76

    Pharmacodynamics

    When drug molecules chemically bindwith cell receptors, pharmacologiceffects are agonism or antagonism:

    Agonists

    Antagonists

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    46/76

    Pharmacodynamics

    Nonreceptor drug actions: relativelyfew drugs act by other mechanisms.

    Antacids

    Osmotic diuretics

    Structurally similar to nutrients

    Metal chelating agents

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    47/76

    Variables That Affect DrugActions

    Drug related variables:

    Dosage

    Route of administration

    Drug-diet interaction

    Drug-drug interactions

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    48/76

    Drug-Drug Interactions

    Additive effects

    Synergism orpotentiation

    Interference Displacement

    Specific antidote

    Decreasedintestinal

    absorption due tobinding

    activation ofenzymes

    Increasedexcretion

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    49/76

    Client Related Variables

    Age

    Body weight

    Genetic &ethniccharacteristics

    Gender

    Pathologicconditions

    Psychologicalconsiderations

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    50/76

    AGE

    Children

    Pregnancy

    Newborns

    Older infants

    1 -12 year olds

    After age 12

    Older adults (65 & over)

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    51/76

    Body Weight

    Larger than average person requiresmore than average person.

    Nurse may have to calculate by mgper kg of weight.

    Fat cells may store drug and releaselater.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    52/76

    Gender

    Altered responses to drugs have beendemonstrated possibly due tohormonal influence.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    53/76

    Pathologic Conditions

    Disorders may cause an alteration inthe pharmacokinetic process:

    Hypotension, shock, low plasma

    Vomiting, diarrhea, malabsorption

    Liver or kidney disease

    Malnutrition

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    54/76

    Psychological Considerations

    Placebo response

    Attitude and expectations

    Compliance

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    55/76

    Adverse Effects of Drugs

    All drugs can produce adverse effects

    May be common, rare, mild or severe

    May occur with usual therapeuticdoses of drugs and are often calledside effects.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    56/76

    Adverse Effects of Drugs

    CNS effects

    GI effects

    Hematologic effects

    Hepatotoxicity

    Nephrotoxicity

    HypersensitivityDrug fever

    Idiosyncrasy

    Drug dependence Carcinogenicity

    Teratogenicity

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    57/76

    Tolerance and Cross-Tolerance

    Drug tolerance

    Cross-tolerance

    Tachyphylaxis

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    58/76

    Questions?

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    59/76

    Nursing Process in DrugTherapy

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    60/76

    Objectives

    Discuss general principles of drugtherapy.

    Identify information to be included ina medication history.

    Identify the Food and DrugAdministration Pregnancy Categories

    for drugs.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    61/76

    Introduction

    Drug therapy is one of the manynursing responsibilities in client care.To fulfill this responsibility the nurse

    must be: Be knowledgeable about pharmacology

    Monitor responses to drug therapy

    Teach clients and families about drugs

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    62/76

    Using Prototypes Approach toStudy Pharmacology

    Concentrate on therapeuticclassifications, groups of drugs &prototypes of those groups.

    Know major characteristics for agroup.

    Set guidelines for effective study

    L l R ibiliti f th

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    63/76

    Legal Responsibilities of theNurse

    Nurses are legally empowered to givemedications ordered by licensedphysicians and dentists (in all states

    but GA, NPs).

    When giving medications, the nurse islegally responsible for safe and

    accurate administration (5 Rights).

    Legal Responsibilities of the

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    64/76

    Legal Responsibilities of theNurse

    The nurse is expected to have sufficient drugknowledge to recognize & question erroneous orders.

    The nurse is responsible for storing narcotics & othercontrolled substances in locked containers, administeronly to people for whom they are prescribed,recording each dose given on the appropriate form &on MAR, counting the amount of each drug at the endof shift and reporting any discrepancies.

    Legal Responsibilities of the

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    65/76

    Legal Responsibilities of theNurse

    The nurse is expected to observeclients for therapeutic & adverseeffects, as well as, teach clients safe

    and effective self-administration ofdrugs when indicated.

    Medication errors can be eliminated

    by following safe practices &guidelines.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    66/76

    Applying the Nursing Process

    The nursing process is a systematic way ofgathering information and using thatinformation to plan, provide, and toevaluate client care and outcomesrequired for drug therapy.

    AssessmentNursing diagnosisPlanning/goals

    Nursing interventionsEvaluation

    General Principles of Drug

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    67/76

    General Principles of DrugTherapy

    The goal of drug therapy

    Benefits should outweigh the adverseeffects

    Drug therapy should be individualized

    Drug costs and effects on quality oflife should be considered

    General Drug Selection &

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    68/76

    General Drug Selection &Dosage Considerations

    Use as few drugs in as few doses aspossible

    Individual drugs allow greater flexibility &

    individualization of dosage than fixed The least amount of the least potent drug

    that will yield therapeutic benefit should begiven to decrease adverse effects.

    General Drug Selection &

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    69/76

    General Drug Selection &Dosage Considerations

    Recommended dosages are listed inamounts likely to be effective for mostpeople, but are only guidelines to beinterpreted according to client

    characteristics. Treatment with a particular drug can bestarted rapidly or slowly.

    Different salts of the same drug rarelydiffer pharmacologically.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    70/76

    Drug Therapy in Children

    Special considerations Pharmacokinetics less predictable Fewer studies/ less research Neonates immature kidney/liver function Most meds given to adults are given to

    children as well Use general principles, techniques of drug

    administration as with adults but with

    additional guidelines

    Additional Guidelines for Drug Administration to

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    71/76

    Additional Guidelines for Drug Administration toChildren

    Drug therapy is guided by childs age,weight, and level of growth anddevelopment.

    Choices of drug is often restricted.

    Safe therapeutic dosage ranges are lesswell defined for children.

    Use the oral route of administration whenpossible.

    Use thigh muscle for IM injections. Child-proof containers.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    72/76

    Drug Therapy for Older Adults

    Adverse effects are especially likely tooccur due to physiological changesassociated with aging, pathologic changesdue to disease processes, multiple drug

    therapy for acute and chronic disorders,impaired memory & cognition & difficultyin complying with medication orders.

    The overall goal may be care instead ofcure with efforts to prevent or controlsymptoms & maintain ability of ADLfunction .

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    73/76

    Additional Guidelines for Drug Therapy in theOlder Adult

    Physiologic age (organ function) is moreimportant than chronological age.

    S&S attributed to age may be caused bydrug therapy.

    Medications should be taken only whennecessary.

    Review current meds before prescribingnew medications.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    74/76

    Additional Guidelines for Drug Therapyin the Older Adult

    Give smallest number of effective drugs.

    Give for shortest effective time needed andreassess periodically.

    Smallest number of doses necessaryprescribed to least disrupt routine.

    Start slow, go slow.

    Use non-drug measures as much as

    possible.

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    75/76

    Additional Guidelines for Drug Therapyin the Older Adult

    Long term drug therapy - home safety/effectiveness guidelines: Label containers/Magnifying glass Use easy open containers

    Special devices & methods Enlist help of family members Observe for changes in S&S related to

    adverse drug reactions as opposed to

    aging process

  • 7/30/2019 PNUR 1104 Lecture 1 Overview_sound-1

    76/76

    Questions?